Add To Watchlist
Share URL
About The Company
CEO
Mr. Charles A. Strongo M.B.A., BA, MBA
Market Cap
223.19 Thousand USD
Sector
Healthcare
Website
https://gwhpcorp.comDescription
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States.
Read More
Overview
Value
1
Growth
2
Health
23
Management
70
Analyst Opinion
60
Total
31
All Scores Out Of 100
Best Features
- Has a low level of debt
- Low preportion of income is paid as dividend 0
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders 0
- Does not hold enough liquid assets to cover short term liabilities
- Poor overall financial health
- No margin of safety at their current market price
- Poor earnings and cashflow growth
Latest News
Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace
GlobeNewsWire | 13:00 Thu 14 Oct 2021
Read More →
Global WholeHealth Partners Corp. (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart and Amazon as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace
GlobeNewsWire | 13:00 Tue 12 Oct 2021
Read More →
Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021
GlobeNewsWire | 13:00 Wed 29 Sept 2021
Read More →
FDA Approves First COVID-19 Vaccine Which Can Be Distributed by Global WholeHealth Partners Corp (OTC: GWHP) as US Anticipates Considerable Uptick in Vaccination Rates, as Stated in 8K Filing 06/15/21
GlobeNewsWire | 13:00 Tue 24 Aug 2021
Read More →
Market Peers
GWHP
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-697.28%
Revenue Growth (5 Year Average)
-12.28%
Ratings Consensus
Neutral
Share Buybacks
-151.64%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✘
Current Price: 0 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-881.86%
PE/Earnings Growth
N/A
Price/Book
-0.14x
Growth
Growth Score
2
- ✘ 5 Year Average Revenue growth of -12.28% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of -25.64% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of -9.69% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
-12.28%
Earnings Growth
-25.64%
Cashflow Growth
-9.69%
Health
Health Score
23
Altman Z Score
N/A
Piostroski Score
3.00
Debt/Equity
N/Ax
Current Assets/Liabilities
0.01x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
34.15x
Management
Management Score
70
Average Buybacks/Dilution
-151.64%
Recent Buybacks/Dilution
39.81%
5 Year Price Volitility
135.10%
Return On Assets
-27157710.25%
Return On Capital Employed
-257.82%
Return On Equity
459234.98%
Return On Free Cashflow
1115206.29%
Return On Investments
N/A
Analysts
Analyst Opinion
60
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Global WholeHealth Partners Corporation
Currency
USD
Beta
2.128705
Vol Avg
190739
Ceo
Mr. Charles A. Strongo M.B.A., BA, MBA
Cik
0001598308
Cusip
37959N102
Exchange
Other OTC
Full Time Employees
Industry
Diagnostics & Research
Sector
Healthcare
Ipo Date
2021-01-08
Address
227 Avenida Oliva
City
San Clemente
State
CA
Country
US
Zip
92660
Phone
702 318 7554
All financial data provided by FMP